Plain-English translation of NCT06911632 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The MOMENTOUS Study is testing a new artificial intelligence tool that analyzes your heart's electrical activity (measured by a simple heart rhythm test called an ECG) to predict whether you might have undiagnosed high blood pressure in your lungs. Researchers want to know if using this AI tool helps doctors catch this serious condition earlier in people who have interstitial lung disease, a type of scarring lung condition. If the AI flags you as high risk, you may receive additional heart tests to confirm whether you have this hidden lung blood pressure disease.
Many people with scarring lung disease develop dangerously high blood pressure in their lungs without knowing it, and this condition can be missed with standard care. Researchers believe that an AI tool analyzing heart rhythms could help doctors spot these patients sooner, leading to earlier treatment and better outcomes.
You likely qualify if…
You likely don't qualify if…
You will have a heart rhythm test (ECG) at the start of the study. Then you will be randomly assigned to either receive or not receive the AI analysis results — both groups will continue with standard care from your doctors. If you are in the group that receives the AI results and are flagged as high risk, you will be offered additional heart tests (a heart ultrasound and a heart catheterization) as part of the study. The study lasts about 6 months, during which your doctors will track whether you receive a diagnosis of high lung blood pressure.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
United States